Page values for "Amevive"
Jump to navigation
Jump to search
"_pageData" values
1 row is stored for this page| Field | Field type | Value |
|---|---|---|
| _pageID | Integer | 854,884 |
| _pageName | Page | Amevive |
| _pageTitle | String | Amevive |
| _pageNamespace | Integer | 0 |
"definitions" values
1 row is stored for this page| Field | Field type | Value |
|---|---|---|
| Term | Page | Amevive |
| Short_definition | String | Amevive (A-meh-veev) A drug used to treat certain skin conditions and being studied for the treatment of cutaneous (skin-related) T-cell cancer and T-cell non-Hodgkin's lymphoma. Amevive is made by combining part of an antibody with a protein that blocks the growth of some types of T cells. |
| Type | Page | Cancer terms |
| Specialty | Page | Oncology |
| Language | Page | English |
| Source | Page | NCI |
| Comments | String |